Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 3
2017 2
2018 4
2019 3
2021 1
2022 3
2023 1
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Renal Mitochondrial ATP Transporter Ablation Ameliorates Obesity-Induced CKD.
Permyakova A, Hamad S, Hinden L, Baraghithy S, Kogot-Levin A, Yosef O, Shalev O, Tripathi MK, Amal H, Basu A, Arif M, Cinar R, Kunos G, Berger M, Leibowitz G, Tam J. Permyakova A, et al. Among authors: baraghithy s. J Am Soc Nephrol. 2024 Mar 1;35(3):281-298. doi: 10.1681/ASN.0000000000000294. Epub 2024 Jan 11. J Am Soc Nephrol. 2024. PMID: 38200648
Thermoneutrality improves skeletal impairment in adult Prader-Willi syndrome mice.
Braxton TM, Sarpong DE, Dovey JL, Guillou A, Evans B, Castellano JM, Keenan BE, Baraghithy S, Evans SL, Tena-Sempere M, Mollard P, Tam J, Wells T. Braxton TM, et al. Among authors: baraghithy s. J Endocrinol. 2019 Aug 1:JOE-19-0279.R1. doi: 10.1530/JOE-19-0279. Online ahead of print. J Endocrinol. 2019. PMID: 31454785 Free article.
Modulation of Renal GLUT2 by the Cannabinoid-1 Receptor: Implications for the Treatment of Diabetic Nephropathy.
Hinden L, Udi S, Drori A, Gammal A, Nemirovski A, Hadar R, Baraghithy S, Permyakova A, Geron M, Cohen M, Tsytkin-Kirschenzweig S, Riahi Y, Leibowitz G, Nahmias Y, Priel A, Tam J. Hinden L, et al. Among authors: baraghithy s. J Am Soc Nephrol. 2018 Feb;29(2):434-448. doi: 10.1681/ASN.2017040371. Epub 2017 Oct 13. J Am Soc Nephrol. 2018. PMID: 29030466 Free PMC article.
Hepatic targeting of the centrally active cannabinoid 1 receptor (CB1R) blocker rimonabant via PLGA nanoparticles for treating fatty liver disease and diabetes.
Hirsch S, Hinden L, Naim MB, Baraghithy S, Permyakova A, Azar S, Nasser T, Portnoy E, Agbaria M, Nemirovski A, Golomb G, Tam J. Hirsch S, et al. Among authors: baraghithy s. J Control Release. 2023 Jan;353:254-269. doi: 10.1016/j.jconrel.2022.11.040. Epub 2022 Nov 30. J Control Release. 2023. PMID: 36442615 Free PMC article.
17 results